Investment Research & Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.54M | Buy |
7,108
+411
| +6% | +$320K | 2.06% | 12 |
|
|
2025
Q1 | $5.53M | Buy |
6,697
+209
| +3% | +$173K | 2.31% | 11 |
|
|
2024
Q4 | $5.01M | Buy |
6,488
+64
| +1% | +$49.4K | 2.08% | 13 |
|
|
2024
Q3 | $5.69M | Sell |
6,424
-11
| -0.2% | -$9.75K | 2.4% | 9 |
|
|
2024
Q2 | $5.83M | Buy |
6,435
+166
| +3% | +$150K | 2.58% | 8 |
|
|
2024
Q1 | $4.88M | Buy |
6,269
+3,048
| +95% | +$2.37M | 2.24% | 11 |
|
|
2023
Q4 | $1.88M | Buy |
3,221
+168
| +6% | +$97.9K | 0.96% | 30 |
|
|
2023
Q3 | $1.64M | Buy |
3,053
+64
| +2% | +$34.4K | 0.93% | 35 |
|
|
2023
Q2 | $1.4M | Hold |
2,989
| – | – | 0.81% | 38 |
|
|
2023
Q1 | $1.03M | Hold |
2,989
| – | – | 0.66% | 41 |
|
|
2022
Q4 | $1.09M | Hold |
2,989
| – | – | 0.72% | 34 |
|
|
2022
Q3 | $966K | Hold |
2,989
| – | – | 0.72% | 38 |
|
|
2022
Q2 | $969K | Hold |
2,989
| – | – | 0.7% | 37 |
|
|
2022
Q1 | $856K | Buy |
2,989
+32
| +1% | +$9.16K | 0.54% | 38 |
|
|
2021
Q4 | $817K | Buy |
2,957
+562
| +23% | +$155K | 0.5% | 38 |
|
|
2021
Q3 | $556K | Sell |
2,395
-26
| -1% | -$6.04K | 0.37% | 46 |
|
|
2021
Q2 | $556K | Buy |
2,421
+26
| +1% | +$5.97K | 0.37% | 44 |
|
|
2021
Q1 | $447K | Hold |
2,395
| – | – | 0.33% | 42 |
|
|
2020
Q4 | $404K | Hold |
2,395
| – | – | 0.3% | 43 |
|
|
2020
Q3 | $355K | Hold |
2,395
| – | – | 0.29% | 42 |
|
|
2020
Q2 | $389K | Hold |
2,395
| – | – | 0.35% | 42 |
|
|
2020
Q1 | $332K | Hold |
2,395
| – | – | 0.31% | 40 |
|
|
2019
Q4 | $315K | Buy |
+2,395
| New | +$315K | 0.29% | 39 |
|